EFTA01461624

From: Tazia Smith Sent: 5/8/2014 2:23:S0 PM To: jeevacation@ mail.com CC: Nay Gupta ; Paul Moa; Vinit Sahn Subject: Re: Biotech Update... (C) Attachments: pic03979.gif; pic18499.gif; pic14904.gif; pic06061.gif; pic03646.gif; pic17133.gif; pic19498.gif; pic10560.gif; pic07051.gif; pic03128.gif Vahe Stepanian classification: confidential Jeffrey - updating you on your biotech basket because most of the names are struggling to rebound from the recent rotational sell-off, exception is GILD which has good valuation support, showed a strong earnings beat, and is back up to — $79.36 (your avg cost is 579.41). FMI reported earnings after the close yesterday, which were inline but guidance was on the low end. Stock has sold off 15% (down to -424 currently from from a high of $30 yesterday). Please find your updated P/L below. Included SGMO chart - that company reported a moderately better quarter on Tuesday evening, hence the 3% uptick and several positive reports from the competitors across the Street. (Embedded image moved to file: pic03979.gif)Source: Bloomberg and Pershing LLC as of 5/8/14 (Embedded image moved to file: pic18499.gif) From: Tazia smith/db/dbcom To: [email protected], cc: Nay Gupta/db/dbcom@DBEmEA, Paul Morris, , vahe Stepanian/db/dbcomMOBAMERICAS, Vi nit sahni/db/dbcomMOBEmEA Date: 04/22/2014 04:16 PM subject: Re: Biotech update... Gilead beat, shares halted (c) classification: confidential Jeffrey - sure you see this, just making sure, Gilead shares are halted in the after-market following a significant top and bottom-line earnings beat ($1.48 vs $0.92 cons eps, S5bn on the topline vs. expecations of $3.96bn) as you know, you're long 8100 shares at an average price of $79.41, stock closed today at S72.86, just reported. Shares expected to re-open at 4:30pm (Embedded image moved to file: pic14904.gif) From: Tazia Smith/db/dbcom To: [email protected], CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 123776 CONFIDENTIAL SDNY_GM_00269960 EFTA01461624